The present invention discloses a therapeutic device includes a bubble generator configured to generate bubbles. The systems consists of a water pump, a diffuser to diffuse CO2 into the water, a sensor for temperature, a tank for CO2, a pressure regulator to lower the CO2 pressure from the tank, a solenoid valve to turn off and on the flow of CO2, a controller to control the system and a display to show the conditions of the system's operation.

An automated frothing assembly. The automated frothing assembly has a wand module that includes an elongate member having an inlet, one or more outlets, and a fluid passageway extending between and in fluid communication with the inlet and the plurality of outlets. At least one of the one or more outlets extends parallel to a vertical plane that includes the centerline of the elongate member and at an acute angle relative to a horizontal plane that is perpendicular to both the vertical plane and the centerline of the elongate member. The assembly further includes an actuator configured to be operatively coupled to the wand module and to drive the movement of at least a portion of the wand module along an axis, and an electronic controller configured to be electrically coupled to the actuator and to control the operation of the actuator to control the movement of the wand module.

The invention relates to a method for processing a liquid sample situated in a receptacle, wherein an attachment device is attached to the receptacle such that at least one fluid line protrudes into the liquid sample and a fluid is directly dispensed into the liquid sample through the fluid line and/or a portion of the liquid sample is aspirated into the fluid line.

Provided is a liquid supply apparatus which is capable of directly taking in a liquid from a flow channel and appropriately mixing a gas into the liquid when generating-nanobubbles in the liquid using an ultrafine bubble generating apparatus. The liquid supply apparatus comprises a flow channel for a liquid supplied from a liquid supply source and an ultrafine bubble generating apparatus for generating nanobubbles in the liquid. The ultrafine bubble generating apparatus is provided with: a liquid ejector for ejecting the liquid taken in from the flow channel; a gas mixer for pressurizing and mixing a gas into the liquid ejected from the liquid ejector; and a nanobubble-generating nozzle for generating nanobubbles in the liquid by passing the liquid with intermixed gas therethrough. The pressure of the liquid in the flow channel flowing into the liquid ejector from the upstream-side of the liquid ejector is a positive pressure and, between the liquid ejector and the-nanobubble-generating nozzle, the gas mixer pressurizes and mixes the gas into the liquid, which is flowing in a pressurized state toward the nanobubble-generating nozzle.

A sparger device includes a sparge tube having opposed distal ends, an inlet opening, and a plurality of sparge holes along a longitudinal extent of the sparge tube between the opposed distal ends, and a central hub coupled with the sparge tube at a point intermediate the opposed distal ends of the sparge tube, the central hub having a fluid passageway in fluid communication with the sparge tube via the inlet opening.

A system for mixing and mixing processes and structures are disclosed. In addition a nozzle used for mixing is disclosed.

What is presented is a system and method for bubble creation in a fluid injection nozzle for the injection of a gas into a liquid to divide the gas into the smallest possible bubble size with the largest cumulative surface area by maximizing the percentage of gas at the highest possible kinetic energy that is in contact with the liquid. The fluid injection nozzle comprises a convergent inlet for receiving a fluid and a divergent outlet for exhausting the fluid. The divergent outlet has multiple exhaust ports.

An apparatus, buffer solutions and a method are provided for pH control of in vitro dissolution tests used to monitor the drug release rate from solid unit dosage forms which are used to predict their in vivo effects or for quality control purposes. A method of preparing a continuous condition and a clear bicarbonate ion based solution for in vitro dissolution testing of pharmaceutical products is also provided.

An enclosure device is also provided for use in the provision of pH control and stabilization to a bicarbonate based solution used in the in vitro dissolution testing of pharmaceutical products.

A method and system for reduction of particulate and gaseous contaminants from exhaust gas including multiple gas handling systems, a mixing tank, and a mixing system that mixes unprocessed exhaust gas and system fluid, while agitating the system fluid.

A liquid aeration device and method is provided that is configured for insertion into the mouth of a bottle of liquid which includes a battery powered impeller that strikes and aerates the liquid, as it is poured from the bottle. An optional inductive/wireless battery charging feature is also described which allows the aeration device to be recharged.